Linezolid for the Treatment of Infections Caused by Methicillin Resistant Staphylococcus Aureus in Japan

Linezolid for Syphilis Pilot Study

NCT05548426 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Asymptomatic Colonization With S. Aureus After Therapy With Linezolid or Clindamycin for Acute Skin Infections

NCT01619410 ·Status: TERMINATED ·Phase: NA

Randomized Clinical Trial to Compare a Regimen of Trimethoprim-sulfamethoxazole Plus Rifampicin With a Regimen of Linezolid in the Treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA) Infection

NCT00711854 ·Status: COMPLETED ·Phase: PHASE4

Adjunctive Linezolid for the Treatment of Tuberculous Meningitis

NCT04021121 ·Status: COMPLETED ·Phase: PHASE2

A Phase Ⅱ Clinical Study of 9MW1411 Injection in Acute Bacterial Skin and Skin Structure Infections

NCT05339802 ·Status: UNKNOWN ·Phase: PHASE2

Strategies Using Off-Patent Antibiotics for Methicillin Resistant S. Aureus "STOP MRSA"

NCT00729937 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Impact MRSA -PCR on Patient Management

NCT03096405 ·Status: COMPLETED

Prospective Study Into the Performance of the MicroPhage S. Aureus/MSSA/MRSA Test Direct From Blood Culture Positives

NCT01184339 ·Status: COMPLETED

Therapeutic Drug Monitoring for Linezolid in the Treatment of Rifampin-resistant Tuberculosis

NCT06590428 ·Status: RECRUITING ·Phase: NA

A Novel Approach to Methicillin-resistant Staphylococcus Aureus (MRSA) Screening of Colonized Patients

NCT01234831 ·Status: COMPLETED ·Phase: NA

A Study of MK-3009 in Japanese Patients With Skin or Blood Stream Infections Caused by Methicillin-resistant Staphylococcus Aureus (MK-3009-002)

NCT00770341 ·Status: COMPLETED ·Phase: PHASE3

A Phase 2 Trial to Evaluate the Efficacy and Safety of Linezolid in Tuberculosis Patients. (LIN-CL001)

NCT02279875 ·Status: COMPLETED ·Phase: PHASE2

Pharmacokinetic Study of Linezolid for TB Meningitis

NCT03537495 ·Status: COMPLETED ·Phase: PHASE2

GSK1322322 Versus Linezolid in the Treatment of Acute Bacterial Skin and Skin Structure Infection

NCT01209078 ·Status: COMPLETED ·Phase: PHASE2

Inflammation, Intracellular Invasion and Colonization of the Nasal Mucosa by Staphylococcus Aureus

NCT04469348 ·Status: COMPLETED ·Phase: NA

Retrospective Real-word Study of Linezolid for the Treatment of Tuberculous Meningitis

NCT03898635 ·Status: UNKNOWN

ERAdicate S. Aureus in Patients With Bacteremia and Endocarditis

NCT05329168 ·Status: WITHDRAWN ·Phase: PHASE2

MicroPhage S. Aureus / MSSA / MRSA Blood Culture Beta Trial

NCT00814151 ·Status: COMPLETED

Staphylococcus Aureus Toxoids Phase 1-2 Vaccine Trial

NCT01011335 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Investigation of the Correlation Between Plasma Concentration of Linezolid Antibiotic and Treatment Response and Adverse Reactions

NCT03126890 ·Status: UNKNOWN

Trial of a Six-Month Regimen of High-Dose Rifampicin, High-Dose Isoniazid, Linezolid, and Pyrazinamide Versus a Standard Nine-Month Regimen for the Treatment of Adults and Adolescents With Tuberculous Meningitis

NCT05383742 ·Status: RECRUITING ·Phase: PHASE2

A Phase I/IIa Study to Evaluate the Safety, Tolerability and Efficacy of Topical LTX-109 in Subjects Nasally Colonized With Methicillin-resistant/-Sensitive Staphylococcus Aureus (MRSA/MSSA)

NCT01158235 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Study of a Recombinant Staphylococcus Aureus Vaccine (Escherichia Coli) in Healthy Adults

NCT02820883 ·Status: COMPLETED ·Phase: EARLY_PHASE1

Study of the Performance of the KeyPath MRSA/MSSA Blood Culture Test - BTA

NCT01640886 ·Status: TERMINATED

Volatile Organic Compounds in Staphylococcus Aureus Patients

NCT01379053 ·Status: COMPLETED